Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Ultragenyx (NASDAQ: RARE) Falls 44% as Angelman Syndrome Trial Misses Endpoint

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) shares closed down 44% at $14.85 after its trial for Angelman syndrome failed to meet its primary endpoint, marking a clinical setback for the program.

Nitish Kishor | 04 September 2026

4D Molecular Therapeutics (NASDAQ: FDMT) Chief Legal Officer Executes Routine Share Sale

4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) Chief Legal Officer Scott Bizily executed a sequence of option exercises and subsequent sales involving 584 shares at prices between $6.49 and $14.

Nitish Kishor | 04 September 2026

Senti Biosciences (NASDAQ: SNTI) Raises $2 Million via Convertible Notes Ahead of Merger

Senti Biosciences, Inc. (NASDAQ: SNTI) raised $2 million via senior secured convertible notes issued to NSG BioInnovation Fund and established a $2.5 million equity agreement with a Celadon affiliate contingent on its pending merger.

Nitish Kishor | 04 September 2026

Summit Therapeutics (NASDAQ: SMMT) Rises 17% on Ivonescimab Survival Data

Summit Therapeutics Inc. (NASDAQ: SMMT) shares closed up 17% at $17.13 following partner Akeso's report that Chinese Phase 3 results for ivonescimab demonstrated improved survival compared to Merck's Keytruda in lung cancer patients.

Nitish Kishor | 04 September 2026

American Outdoor Brands (NASDAQ: AOUT) Jumps Over 25% After Hours on Q1 Beat

American Outdoor Brands, Inc. (NASDAQ: AOUT) shares surged 25.47% to $12.56 in after-hours trading Thursday after the Missouri-based provider of outdoor products and accessories announced its first-quarter fiscal 2027 results, withEarnings Per Shareof $0.03 topping analysts' expectations by 112%. In the regular session, AOUT …

Nitish Kishor | 04 September 2026

Immuron (NASDAQ: IMRN) Signs Exclusive U.S. Distribution Deal for PROIBS

Immuron Limited (NASDAQ: IMRN) entered into an exclusive distribution agreement within the United States with Calmino Group AB for PROIBS, broadening its digestive wellness lineup alongside Travelan.

Nitish Kishor | 04 September 2026

Clearmind Medicine (NASDAQ: CMND) Agrees to Acquire 51% of Charging Robotics

Clearmind Medicine Inc. (NASDAQ: CMND) entered a definitive agreement to acquire a 51% stake in EV wireless charging company Charging Robotics for $2.5 million plus a $1.5 million 4% loan.

Nitish Kishor | 04 September 2026

Net (NASDAQ: NCPL) Falls Nearly 39% After Board Member Resigns Amid SEC Action

Net appointed Cesar Herrera to itsBoard of Directorsand to its Audit and Compensation Committees, effective August 30, 2026, following the resignation of director Avi Liss.

Nitish Kishor | 04 September 2026

Ionis Pharmaceuticals (NASDAQ: IONS) Gets FDA Approval for Zanvastro in Alexander Disease

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) received FDA approval for Zanvastro to treat Alexander disease in both children and adults.

Nitish Kishor | 04 September 2026

Aethlon Medical (NASDAQ: AEMD) Secures Patent Allowance for Viral Infection Management Technology

Aethlon Medical, Inc. (NASDAQ: AEMD) secured a notice of allowance from the USPTO for a patent regarding technology for managing viral infections and their symptoms.

Nitish Kishor | 04 September 2026
Support

Hi! How can we help you today?

Loading…